STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

Author: Erickson Craig   Veenstra-Vanderweele Jeremy   Melmed Raun   McCracken James   Ginsberg Lawrence   Sikich Linmarie   Scahill Lawrence   Cherubini Maryann   Zarevics Peter   Walton-Bowen Karen   Carpenter Randall   Bear Mark   Wang Paul   King Bryan  

Publisher: Springer Publishing Company

ISSN: 0162-3257

Source: Journal of Autism and Developmental Disorders, Vol.44, Iss.4, 2014-04, pp. : 958-964

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content